Genetic Testing: Delivering personalized patient care | Labcorp
Discover genetic testing insights that improve personalized patient care
The future of genetic testing is happening today. Labcorp empowers providers and patients with meaningful health data that paves the way for new treatments, targeted therapies and individualized healthcare.
Access comprehensive genetic tests easily and confidently
Our tests are developed and delivered by leaders in specialty testing to help you transform data into personal health insights. Labcorp's nationwide network of conveniently located patient service centers makes sample collection easy.
400+ types of genetic tests
across 15 clinical specialty areas
12M+ genetic tests performed
offering a diverse set of clinical data
1,200+ MD and PhD team members
advancing genetic science and breakthroughs
150+ genetic counseling specialists
supporting both patients and clinicians
Look beyond BRCA for a more complete hereditary cancer risk picture
BRCA1 and BRCA2 are essential markers of hereditary breast cancer risk, but they're only part of the picture. Genes such as PALB2, CHEK2, ATM, and TP53 can also influence risk and help guide surveillance, risk-reduction, and treatment decisions.
For many eligible patients, current guidelines support multigene panel testing as a more comprehensive way to assess hereditary cancer risk. Labcorp's hereditary cancer testing portfolio, backed by genetic counseling resources, helps providers make confident, personalized care decisions.
- Hereditary cancer
- Women's health
- Rare disease
Genetic testing for hereditary cancer
Labcorp’s hereditary cancer portfolio provides clarity across the care continuum. Our genetic testing identifies patients at increased risk and delivers trusted, actionable results that inform diagnosis, treatment decisions, and personalized care.
Invitae Common Hereditary Cancers Panel
Invitae Hereditary Breast Cancer STAT Panel
Genetic testing for women’s health
Labcorp’s women’s health genetic testing portfolio delivers insights across every stage of a woman’s life, from preconception through hereditary cancer, helping identify risk early, inform decisions, and support personalized patient management.
Invitae Hereditary Breast and Gyn Cancers Guidelines-Based Panel
Labcorp MaterniT® 21 PLUS cfDNA (NIPT)
Genetic testing for rare disease
Labcorp’s rare disease portfolio helps shorten the diagnostic odyssey, accelerating answers for patients with complex conditions. With testing across cardiology, neurology, pediatrics, and more, we enable confident diagnoses, informed treatment decisions, and clearer care pathways.
Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel
Invitae Primary Immunodeficiency Panel
Provider resources
Advancing healthcare through genetic insights
Biopharma
We collaborate with hundreds of scientists and researchers from biotech and pharmaceutical companies to help you test, validate and bring to market your next pharmaceutical or medical device product.
Commercial Partnerships
Through our capabilities in specialty testing, high-value datasets and global footprint, Labcorp can scale to meet your commercial needs for genetic testing.
Individuals & Patients
With genetic testing supported by genetic counseling, we can help you understand the options that may be best for you.
Latest in genetics insights
The Pulse of Genetic Counselors
At Labcorp, now including Invitae, we know that without genetic counselors, advancing personalized patient care through genetics wouldn’t be possible. But genetic counselors face significant challenges that impact their ability to do the work efficiently and effectively. The Pulse of Genetic Counselors report shares motivations and challenges from over 100 genetic counselors.
Questions? We’re here to help.
Our team is available to answer questions and guide you—whether you’re a patient, provider, health plan, payer or otherwise.